FIGURE

Figure 5

ID

ZDB-FIG-230217-52

Publication

Kowald et al., 2023 - Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer

Other Figures

All Figure Page

Back to All Figure Page

Figure 5

The clinical responses of three NMIBC patients are mirrored by the BCG treatment response of ZTX models. (A) Cartoon illustrating the experimental set-up. Cryo-preserved patient tumor tissues were dissociated, fluorescently labelled, and subcutaneously injected into the PVS of 48 h old zebrafish larvae with or without BCG. (B) Graph showing the relative tumor size of the six different ZTX models without BCG treatment quantified at 3 days post-injection (dpi). (C–H) Graphs comparing relative tumor sizes of BCG co-injected and untreated control ZTX groups quantified at 3 dpi. n = 20 injected embryos per group; ns = not significant; * = p < 0.05; *** = p < 0.0001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cells